Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1986 Feb;39(2):220–222. doi: 10.1136/jcp.39.2.220

Inhibition of Pseudomonas aeruginosa from cystic fibrosis by selective media.

K Fonseca, J MacDougall, T L Pitt
PMCID: PMC499682  PMID: 3081597

Abstract

Pseudomonas Isolation Agar (selective agent, Irgasan, 25 mg/1) and Pseudomonas Selective Agar (selective agents, cetrimide 200mg/1 and nalidixic acid 15 mg/1) inhibited some strains of P aeruginosa from cystic fibrosis sputum but did not inhibit isolates from other sources. Of 200 cystic fibrosis isolates, 22 were inhibited by 16 mg/1 Irgasan, 45 by 8 mg/1 nalidixic acid, and 15 by 128 mg/1 cetrimide. We recommend that cystic fibrosis sputum should be cultured on selective and non-selective media to maximise the isolation of P aeruginosa.

Full text

PDF
220

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Irvin R. T., Govan J. W., Fyfe J. A., Costerton J. W. Heterogeneity of antibiotic resistance in mucoid isolates of Pseudomonas aeruginosa obtained from cystic fibrosis patients: role of outer membrane proteins. Antimicrob Agents Chemother. 1981 Jun;19(6):1056–1063. doi: 10.1128/aac.19.6.1056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. KING E. O., WARD M. K., RANEY D. E. Two simple media for the demonstration of pyocyanin and fluorescin. J Lab Clin Med. 1954 Aug;44(2):301–307. [PubMed] [Google Scholar]
  3. King A., Warren C., Shannon K., Phillips I. The in vitro antibacterial activity of cefotaxime compared with that of cefuroxime and cefoxitin. J Antimicrob Chemother. 1980 Jul;6(4):479–494. doi: 10.1093/jac/6.4.479. [DOI] [PubMed] [Google Scholar]
  4. Penketh A., Pitt T., Roberts D., Hodson M. E., Batten J. C. The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis. Am Rev Respir Dis. 1983 May;127(5):605–608. doi: 10.1164/arrd.1983.127.5.605. [DOI] [PubMed] [Google Scholar]
  5. RAWLINS G. A. Liquefaction of sputum for bacteriological examination. Lancet. 1953 Sep 12;265(6785):538–539. doi: 10.1016/s0140-6736(53)90275-x. [DOI] [PubMed] [Google Scholar]
  6. Wong K., Roberts M. C., Owens L., Fife M., Smith A. L. Selective media for the quantitation of bacteria in cystic fibrosis sputum. J Med Microbiol. 1984 Apr;17(2):113–119. doi: 10.1099/00222615-17-2-113. [DOI] [PubMed] [Google Scholar]
  7. el-Nima E. I. The synergism between cetrimide and antibiotics against Pseudomonas aeruginosa. Zentralbl Bakteriol Mikrobiol Hyg A. 1984 Oct;258(1):120–127. doi: 10.1016/s0176-6724(84)80016-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES